original ) (raw )Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Lisa Rydén
BMC cancer, 2017
View PDFchevron_right
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
Peter Ell
JNCI Journal of the National Cancer Institute, 2006
View PDFchevron_right
Survival and recurrence with or without axillary dissection in patients with invasive breast cancer and sentinel node metastasis
Vanessa Sanvido
Scientific Reports
View PDFchevron_right
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Lorenzo Orzalesi
The Lancet Oncology, 2014
View PDFchevron_right
ARTICLES Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
Tholkifl Abdullah
2015
View PDFchevron_right
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981- 22023)
Robert Mansel
2014
View PDFchevron_right
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023)
Robert Mansel
Journal of Clinical Oncology, 2013
View PDFchevron_right
Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer
CK Axelsson
British Journal of Surgery, 2009
View PDFchevron_right
Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses
Malcolm Reed
SpringerPlus, 2016
View PDFchevron_right
Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
Nick Iarrobino
Advances in Radiation Oncology
View PDFchevron_right
A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer
peter schrenk
The Breast, 2007
View PDFchevron_right
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
André Robidoux
The Lancet Oncology, 2010
View PDFchevron_right
Axillary Dissection in Breast Cancer Patients with Metastatic Sentinel Node: To Do or Not to Do? Suggestions from Our Series
Eugenio Zanon
ISRN Oncology, 2011
View PDFchevron_right
Sentinel node positive breast cancer patients who do not undergo axillary dissection: Are they different?
Sylvester Sterioff
Surgery, 2008
View PDFchevron_right
Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer
merdan fayda
JAMA, 2011
View PDFchevron_right
Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011
Sukamal Saha
Journal of Clinical Oncology, 2008
View PDFchevron_right
The Management of Axillary Lymph Nodes in Breast Cancer - A Retrospective Single-Centre Study
Ciprian Cirimbei
2021
View PDFchevron_right
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
J. de Wilt
BMC Cancer, 2015
View PDFchevron_right
Sentinel node biopsy is not an alternative to axillary dissection in breast cancer
Frederick Moffat
Journal of Surgical Oncology, 2001
View PDFchevron_right
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
Julia van Steenhoven
Annals of Surgical Oncology
View PDFchevron_right
Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis
Zahra Sadri
Asian Pacific Journal of Cancer Prevention
View PDFchevron_right
Patterns of Axillary Surgical Care for Breast Cancer in the Era of Sentinel Lymph Node Biopsy
Deborah Axelrod
Annals of Surgical Oncology, 2009
View PDFchevron_right
Axillary Recurrence Rate Following Negative Sentinel Node Biopsy for Invasive Breast Cancer: Long-Term Follow-Up
Michelle Davis
Annals of Surgical Oncology, 2009
View PDFchevron_right
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
Sukamal Saha
JAMA, 2011
View PDFchevron_right
Sentinel Lymph Node Biopsy Alone Has No Adverse Impact on the Survival of Patients with Breast Cancer
Hiroyuki Takei
The Breast Journal, 2006
View PDFchevron_right
Axillary lymph node dissection could be omitted in the breast cancer patients with a limited sentinel lymph node involvement following neoadjuvant systemic treatment
Manuela Avirović
Libri Oncologici Croatian Journal of Oncology, 2021
View PDFchevron_right
Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: A long term follow‐up analysis
Hans Fabry
Journal of Surgical Oncology, 2004
View PDFchevron_right
Clinicopathologic Features Associated With Having Four or More Metastatic Axillary Nodes in Breast Cancer Patients With a Positive Sentinel Lymph Node
Ken Stater
Annals of Surgical Oncology, 2006
View PDFchevron_right
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution
Eugenio Maiorano
Cancer, 2005
View PDFchevron_right